Basel – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Matt Sause (45), currently Head of Roche Diagnostics’ North America Region, will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023. Thomas Schinecker, the incumbent CEO of the Diagnostics Division and new Roche CEO as of 15 […]
Boston, MA & Singapore – AIM Biotech announced the launch of the organiX System, a lab tool to closely model human disease by adding vascularization and immune competence to organoids, spheroids and tumor biopsies. Adding vascularization and immune cells to a disease model creates a more defined and tunable microenvironment to more closely emulate the […]
The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has successfully closed the acquisition of Albumedix Ltd. as of September 30, 2022. Albumedix is a leader in the field of recombinant albumin-based solutions and based in Nottingham, UK. This press release contains forward-looking statements about the future development of the Sartorius […]
RNA synthesis platform to target synthesis lengths greater than 100-nt, large-scale GMP manufacturing, and novel therapeutic modifications in collaboration with industry partners Advanced-stage technology with over six years of development at the Wyss Institute at Harvard University, co-founded by Dr. George Church of Harvard Medical School, and the first spin-out from the Northpond Labs Alliance […]
This week, KeyGene installed an MGI DNA-sequencing machine: a DNBSEQ – G400RS. KeyGene is the first to acquire and install this new sequencer in the Netherlands, a leading country in plant breeding and plant research. “The new MGI sequencing technology offers a range of new possibilities for technology innovation for crop improvement’ said Dick Roelofs, […]
New sequencing technologies and capabilities will accelerate the genomic discoveries and clinical insights needed to transform human health Revolutionary NovaSeq X Series sets new benchmark for speed, scale, accuracy, and sustainability SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced multiple breakthrough sequencing innovations at its inaugural […]
Funding will support expanded offerings for drug development, regenerative medicine as fiber-optic instrument-maker broadens presence in life science market New investment will also bolster leadership team and support U.S. expansion AMSTERDAM – Optics11 Life, the fiber optics life science instrumentation company, announced today €5 million in new venture capital from FORWARD.one and returning investor Value […]
New technology enables highest levels of accuracy at immense scale, with the power to sequence more than 20,000 genomes per year Our most sustainable high-throughput sequencer delivers 90% reduction in packaging and 50% reduction in plastic waste, and eliminates dry ice shipments, expanding global access to genomic medicine SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a […]
Monoclonal antibodies specific and potent against a variety of SARS-CoV-2 protein domains Wide selection of high purity SARS-CoV-2 recombinant proteins Robust and optimized ELISA kits to quantify SARS-CoV-2 virus-triggered human IgM/IgG IRVINE, Calif. — MP Biomedicals, LLC has recently expanded its portfolio of COVID-19 related research products to include a wide selection of highly pure SARS-CoV-2 […]
bit.bio adds two new human cell products to address the translation gap and accelerate research and drug discovery for neurodegenerative disease bit.bio announces an expansion to its product portfolio to accelerate research into neurodegenerative diseases Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) disease model offer a scalable and reproducible in vitro system to model […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
